These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 36892705)
1. Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism. Hosseini E; Kohan-Ghadr HR; Bazrafkan M; Amorim CA; Askari M; Zakeri A; Mousavi SN; Kafaeinezhad R; Afradiasbagharani P; Esfandyari S; Nazari M J Assist Reprod Genet; 2023 May; 40(5):1173-1185. PubMed ID: 36892705 [TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome: A joint, potential therapeutic target in management of COVID-19 and fertility problems. Bazrafkan M; Hosseini E; Nazari M; Amorim CA; Sadeghi MR J Reprod Immunol; 2021 Nov; 148():103427. PubMed ID: 34563758 [TBL] [Abstract][Full Text] [Related]
3. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Zhao N; Di B; Xu LL Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243 [TBL] [Abstract][Full Text] [Related]
4. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention. Zhang J; Ma X; Liu F; Zhang D; Ling J; Zhu Z; Chen Y; Yang P; Yang Y; Liu X; Zhang J; Liu J; Yu P Front Immunol; 2023; 14():1203389. PubMed ID: 37868953 [TBL] [Abstract][Full Text] [Related]
5. Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors. Diarimalala RO; Wei Y; Hu D; Hu K Front Cell Infect Microbiol; 2023; 13():1218039. PubMed ID: 37360532 [TBL] [Abstract][Full Text] [Related]
6. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection. Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL Front Immunol; 2023; 14():1270081. PubMed ID: 37920468 [TBL] [Abstract][Full Text] [Related]
8. Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies. He Q; Hu D; Zheng F; Chen W; Hu K; Liu J; Yao C; Li H; Wei Y Viruses; 2024 Jan; 16(2):. PubMed ID: 38399989 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein. Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919 [TBL] [Abstract][Full Text] [Related]
10. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells. Sur S; Steele R; Isbell TS; Ray R; Ray RB mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188 [TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins. Kim NE; Song YJ J Microbiol; 2022 Mar; 60(3):300-307. PubMed ID: 35089584 [TBL] [Abstract][Full Text] [Related]
12. [Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection]. Chemarin M; Dufies O; Mazet A; Mellan E; Coudereau R; Py BF; Boyer L; Venet F Med Sci (Paris); 2022; 38(6-7):545-552. PubMed ID: 35766852 [TBL] [Abstract][Full Text] [Related]
14. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection. Islamuddin M; Mustfa SA; Ullah SNMN; Omer U; Kato K; Parveen S Inflammation; 2022 Oct; 45(5):1849-1863. PubMed ID: 35953688 [TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice. Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342 [TBL] [Abstract][Full Text] [Related]
16. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils. Leal VNC; Andrade MMS; Teixeira FME; Cambui RAG; Roa MEGV; Marra LG; Yamada SM; Alberca RW; Gozzi-Silva SC; Yendo TM; Netto LC; Duarte AJS; Sato MN; Pontillo A Scand J Immunol; 2023 Mar; 97(3):e13247. PubMed ID: 36541819 [TBL] [Abstract][Full Text] [Related]
17. [Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19]. Ren Z; Che P; Li Z; Mo M; Zhang S; Zhang Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):844-850. PubMed ID: 34533131 [TBL] [Abstract][Full Text] [Related]
18. The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury. Irrera N; Russo M; Pallio G; Bitto A; Mannino F; Minutoli L; Altavilla D; Squadrito F Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867310 [TBL] [Abstract][Full Text] [Related]
19. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19. Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881 [TBL] [Abstract][Full Text] [Related]
20. CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation. Rodrigues TS; Caetano CCS; de Sá KSG; Almeida L; Becerra A; Gonçalves AV; Lopes LS; Oliveira S; Mascarenhas DPA; Batah SS; Silva BM; Gomes GF; Castro R; Martins RB; Avila J; Frantz FG; Cunha TM; Arruda E; Cunha FQ; Nakaya H; Cunha LD; Fabro AT; Louzada-Junior P; de Oliveira RDR; Zamboni DS J Infect Dis; 2023 Jun; 227(12):1364-1375. PubMed ID: 36763010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]